SYS-CON MEDIA Authors: Jason Bloomberg, Kevin Benedict, David H Deans, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

IP Infusion Launches VirNOS™ Virtual Network Platform Based on Network Functions Virtualization

IP Infusion, Inc., a leading provider of intelligent network software for enhanced Ethernet and IP services, today announced the availability of VirNOS™, a virtual network platform based on Network Functions Virtualization (NFV) to help network operators to reduce their CapEx and OpEx costs, accelerate time-to-market for new services, increase agility, and deploy new network services faster.

Network operators face the challenge of integrating and maintaining a variety of proprietary hardware, while coping with increased energy costs, growing capital investment and space requirements. Many core networking services, including switching, routing, load balancing and VPN, can now be performed by software either running directly on x86-64 servers or running as virtual machines, instead of requiring expensive networking equipment. Therefore IT organizations are migrating networking functions to standard, high-volume server environments and replacing dedicated network hardware with virtualization software that run on commodity servers.

IP Infusion’s VirNOS NFV-based software platform virtualizes network functions to give network operators a cost-effective approach to deploy and manage their networking services. With VirNOS, network service development can benefit from:

  • Supports flow switching via OpenFlow for easy deployment of innovative routing and switching protocols
  • Ideal for virtual machines, high-security networks and next generation IP-based mobile networks
  • Uses Intel DPDK to provide programming framework that scales and enables faster development of high speed data packet networking applications
  • Supports IPv4 and IPv6 dynamic routing protocols (BGP, OSPF, ISIS, Unicast)
  • Leverages mature code base of ZebOS-XP® -- IP Infusion’s industry proven platform

“With the NFV capabilities of IP Infusion’s new VirNOS platform, network operators can offer new network services more readily, and scale services up and down to support their changing business requirements,” said Kiyo Oishi, CEO and president of IP Infusion. “We are partnering with several network equipment manufacturers to package our NFV technology into their software offerings which will generate more innovative network services and help their customers to offer new revenue models and growth opportunities.”

For more information on how IP Infusion is delivering on network functions virtualization technology, please visit www.ipinfusion.com.

About IP Infusion

IP Infusion is the Software-Defined Networking (SDN) company relied on for more than a decade by equipment manufacturers to help deliver products faster with lower costs and better differentiation. Over 250 customers, including all major networking equipment manufacturers, use IP Infusion’s SDN platform ZebOS to build products that address the evolving needs of cloud, carrier and mobile networking. IP Infusion’s technology is deployed in networks with the highest levels of reliability across five continents that transport billions of mobile messages and provide the foundation for public, private and hybrid clouds. IP Infusion is headquartered in Sunnyvale, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at www.ipinfusion.com.

IP Infusion, VirNOS, ZebOS, and ZebOS-XP are trademarks or registered trademarks of IP Infusion. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.